Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Q4 2019 Twist Bioscience Corp Earnings Call Transcript

Dec 11, 2019 / 09:30PM GMT
Release Date Price: $26 (+3.92%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the fiscal 2019 fourth quarter and full year financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Jim Thorburn, Chief Financial Officer. Thank you, and please go ahead, sir.

James M. Thorburn
Twist Bioscience Corporation - CFO

All right. Thank you, Chris. Good afternoon, everyone, and thank you for joining us today for Twist Bioscience conference call to review our fiscal 2019 fourth quarter and full year financial results and business progress. Please review the press release we issued earlier today, which is available at our website at www.twistbioscience.com.

With me on today's call is Dr. Emily Leproust, CEO and Founder -- Co-Founder of Twist. Emily will begin with a review of overall progress on Twist businesses. I will report on our financial and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot